Menopause and Anxiety: Understanding the Mental Health Connection
%20Medium.jpeg)
The relationship between menopause and anxiety is physiological, not imagined. While menopause has long been framed as a primarily physical transition, a growing body of evidence demonstrates that the hormonal changes involved have direct effects on brain chemistry, mood regulation, and the stress response.
Menopause is defined as the point at which a woman has not had a menstrual period for 12 consecutive months. The transition leading up to that point, called perimenopause, can begin several years earlier and is characterised by fluctuating hormone levels that rarely follow a predictable pattern. It is during this transitional phase that anxiety symptoms are most commonly reported.
A 2018 study published in the journal Menopause found that women in the menopausal transition experienced a statistically significant increase in anxiety symptoms compared to premenopausal controls, even after accounting for life stressors, sleep disruption, and prior psychiatric history. The study concluded that hormonal changes themselves were an independent contributor to anxiety onset.
The Australasian Menopause Society notes that psychological symptoms, including anxiety, low mood, and difficulty concentrating, are among the most commonly reported symptoms of the menopausal transition. Despite this, they are also among the most commonly undiagnosed. Many women present to their GP with individual complaints rather than recognising the broader pattern.
This is not a failure of awareness on anyone's part. It is a reflection of how menopause has historically been understood: as something physical, something temporary, and something to be endured rather than treated. That understanding is changing.
The link between hormones and mental health is well established in medical literature, but the specific mechanisms involved during menopause are worth understanding in detail.
Oestrogen and the Brain
Oestrogen is not only a reproductive hormone. It plays a significant role in the regulation of neurotransmitters that govern mood, including serotonin, noradrenaline, and gamma-aminobutyric acid (GABA). Serotonin is closely associated with feelings of wellbeing and calm. GABA functions as the brain's primary inhibitory neurotransmitter, meaning it helps to dampen the nervous system's stress response. When oestrogen levels are stable, these systems tend to function predictably.
During perimenopause and menopause, oestrogen levels do not simply decline in a straight line. They fluctuate, sometimes dramatically, before eventually settling at a lower baseline. Research published in The Journal of Clinical Endocrinology & Metabolism has shown that it is these fluctuations, rather than the final lower level, that are most strongly associated with mood disturbance and anxiety. This helps explain why anxiety often peaks during perimenopause and may improve somewhat after menopause is established.
Progesterone's Calming Role
Progesterone has a natural calming effect on the nervous system. It is metabolised into allopregnanolone, a neurosteroid that enhances GABA activity. As progesterone production declines during the menopausal transition, the brain effectively loses a source of natural anxiolytic support. For some women, this manifests as a new sensitivity to stress, a feeling of being more easily overwhelmed, or an inability to "switch off" at the end of the day.
The Cortisol Connection
Declining oestrogen and progesterone can also affect the hypothalamic-pituitary-adrenal (HPA) axis, the system that governs the body's stress response. Research from the Australian Institute of Health and Welfare suggests that dysregulation of the HPA axis during the menopausal transition may lower the threshold at which the stress response is activated. In practical terms, this means situations that were previously manageable may begin to trigger an anxiety response that feels disproportionate.
Sleep Disruption as an Amplifier
Sleep disturbance is extremely common during menopause, whether caused by night sweats, hormonal changes affecting sleep architecture, or the anxiety itself. The relationship between poor sleep and anxiety is bidirectional. Broken sleep increases vulnerability to anxiety, and anxiety makes sleep harder to achieve. The Sleep Health Foundation of Australia identifies the menopausal transition as a period of significantly elevated insomnia risk, and notes that untreated sleep problems can perpetuate and worsen co-occurring anxiety.
One of the challenges of menopause anxiety is that it can be difficult to identify as menopause-related, particularly if a woman has never experienced significant anxiety before. The symptoms can be physical, psychological, or both, and they frequently overlap with other conditions.
Psychological Symptoms
Common psychological presentations of menopause-related anxiety include persistent worry that feels difficult to control, a sense of dread or foreboding without a clear cause, difficulty concentrating or making decisions, irritability that feels out of character, and a feeling of being constantly "on edge." Some women describe it as a fundamental shift in their baseline state, as though the emotional thermostat has been recalibrated without their consent.
Physical Symptoms
Anxiety during menopause often presents with physical symptoms that can be mistaken for other conditions. These may include a racing or pounding heart (palpitations), tightness in the chest, shortness of breath, muscle tension (particularly in the jaw, shoulders, and neck), nausea or digestive upset, dizziness, and trembling or tingling sensations. Because these symptoms overlap with cardiac and thyroid conditions, it is important to have them assessed by a doctor rather than assuming they are anxiety-related.
Timing and Pattern
Menopause-related anxiety typically follows a pattern that aligns with the broader hormonal transition. Symptoms may worsen in the years leading up to the final menstrual period and then gradually ease after menopause is established. They are often accompanied by other menopausal symptoms such as hot flushes, night sweats, or changes in menstrual patterns. If anxiety symptoms have appeared or significantly worsened during the age range typically associated with perimenopause (40 to 55), the hormonal connection is worth exploring with a doctor.
Menopause-related anxiety and generalised anxiety disorder (GAD) share many surface-level similarities, which is one reason the two are frequently confused. Understanding the differences matters because the treatment approach may vary.
Generalised Anxiety Disorder
GAD is a chronic condition characterised by excessive, persistent worry about a range of everyday situations. According to the Royal Australian College of General Practitioners, GAD is diagnosed when anxiety and worry are present on more days than not for at least six months and are accompanied by symptoms such as restlessness, fatigue, difficulty concentrating, irritability, muscle tension, and sleep disturbance. GAD is not linked to a specific hormonal trigger and typically requires long-term management.
Menopause-Related Anxiety
Menopause-related anxiety, by contrast, has a temporal relationship with the hormonal transition. It may be a woman's first experience of significant anxiety, or it may represent a marked worsening of previously manageable symptoms. It often co-occurs with other menopausal symptoms and may respond to hormonal treatments in addition to, or sometimes instead of, standard anxiety treatments.
Where They Overlap
The overlap is real and important. Some women will have pre-existing GAD that worsens during menopause. Others will develop menopause-related anxiety that meets the clinical threshold for a GAD diagnosis. The distinction is not always clear-cut, and a thorough clinical assessment is needed to understand which factors are contributing and to develop an appropriate treatment plan.
Beyond Blue notes that anxiety symptoms should always be taken seriously regardless of their suspected cause, and that effective treatments exist for both hormonally driven and non-hormonally driven anxiety.
Treatment for menopause anxiety is not one-size-fits-all. The most effective approach depends on the severity of symptoms, whether other menopausal symptoms are present, the woman's medical history, and her personal preferences. In many cases, a combination of approaches is most helpful.
Psychological Therapies
Cognitive behavioural therapy (CBT) has a strong evidence base for the treatment of anxiety, including anxiety that occurs during the menopausal transition. A 2019 Cochrane review found that CBT was effective in reducing anxiety and depressive symptoms in menopausal women, with benefits sustained over time. CBT works by helping to identify and reframe thought patterns that maintain the anxiety cycle, and by building practical coping strategies.
Acceptance and commitment therapy (ACT) and mindfulness-based stress reduction (MBSR) have also shown promise in clinical trials involving menopausal women. These approaches may be particularly helpful for women who find that their anxiety is closely linked to the uncertainty and loss of control that the menopausal transition can bring.
In Australia, Medicare-rebated psychological therapy is available through a Mental Health Care Plan, which can be arranged by a GP. This typically provides access to up to 10 individual sessions with a psychologist per calendar year.
Medication Options
For moderate to severe anxiety, medication may be recommended alongside psychological therapy. The most commonly prescribed medications for menopause-related anxiety include selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs). These are effective for both anxiety and some vasomotor symptoms of menopause (such as hot flushes), which can make them a practical choice for women experiencing both.
Hormone replacement therapy (HRT) may also be considered when anxiety is clearly linked to hormonal changes and co-occurs with other menopausal symptoms such as hot flushes, night sweats, or vaginal dryness. The Australasian Menopause Society notes that HRT can improve mood and reduce anxiety in some women, though it is not a first-line treatment for anxiety on its own. HRT must be prescribed by a doctor following an individual risk assessment.
All prescription medications require a consultation with a licensed medical practitioner. A doctor can discuss the risks and benefits of each option in the context of your specific health history.
Lifestyle Approaches
While lifestyle measures are not a substitute for clinical treatment when symptoms are significant, they can play a meaningful supporting role. Evidence-based lifestyle approaches that may help manage menopause anxiety include regular physical activity (the Australian Government Department of Health recommends at least 150 minutes of moderate-intensity activity per week), stress reduction practices such as yoga, meditation, or breathing exercises, limiting caffeine and alcohol intake (both can worsen anxiety symptoms and disrupt sleep), maintaining consistent sleep habits, and staying socially connected.
The Healthdirect Australia menopause resource emphasises that lifestyle approaches are most effective when used alongside professional support, not as a replacement for it.
Feeling anxious during menopause?
Deciding when to seek professional help for anxiety is a deeply personal decision, and there is no threshold of suffering that needs to be reached before it becomes "justified." If anxiety is affecting your ability to enjoy daily life, maintain relationships, perform at work, or sleep, that is reason enough.
There are some signs that suggest it is particularly important to speak with a doctor sooner rather than later. These include anxiety symptoms that are worsening over time, physical symptoms such as palpitations or chest tightness that need clinical assessment, difficulty functioning at work or in personal relationships, persistent sleep disruption, use of alcohol or other substances to manage symptoms, and feelings of hopelessness or despair.
A GP is the right starting point. A thorough assessment can help determine whether symptoms are related to the menopausal transition, a pre-existing or co-occurring mental health condition, or another medical cause that requires investigation. Blood tests may be recommended to rule out thyroid dysfunction, anaemia, or other conditions that can mimic anxiety.
If you or someone you know is experiencing a mental health crisis, please seek immediate support:
- Beyond Blue: 1300 22 4636 (available 24/7)
- Lifeline: 13 11 14 (available 24/7)
- Emergency Services: 000
These services are free, confidential, and available to all Australians.
Abby Health is Australia's online-first clinic, and menopause care is one of the areas where the model makes the most difference. Many women delay seeking help for menopause anxiety because the process of getting an appointment feels like one more thing on an already overwhelming list. Long wait times, difficulty finding a GP who takes menopause seriously, and the discomfort of starting the conversation from scratch each time are all barriers that should not exist.
Abby Health offers consultations seven days a week, 365 days a year. Appointments are bulk billed for eligible patients with a valid Medicare card. The care network includes experienced GPs who understand the overlap between menopause and mental health and can assess both in a single consultation.
Continuity of care matters for conditions like menopause anxiety, where treatment often requires adjustment over time. At Abby Health, 71% of patients rebook with the same clinician, which means fewer repeated histories and more time spent on what actually matters.
During a consultation, your clinician can assess your symptoms, discuss treatment options, and, where appropriate, initiate a Mental Health Care Plan to provide access to Medicare-rebated psychology sessions. If medication is indicated, prescriptions can be provided during the consultation itself.
Every consult is supported by Abby AI, our clinical decision-support tool, which surfaces relevant patient history, symptoms, and risk signals so your clinician starts the conversation informed. Abby AI does not diagnose or prescribe. It ensures that nothing in your health story is overlooked, particularly when multiple concerns are being addressed at once.
If you have been putting off this conversation, this is a good place to start. The discomfort of not knowing is almost always worse than the conversation itself.
Editorial Standards
Notice something that doesn’t look right? Let us know at support@abbyhealth.app
Authors
.avif)
